Peter Bonate, based in Northbrook, IL, US, is currently a Executive Director, Clinical Pharmacology and Exploratory Development, PKMS New Technologies at Astellas Pharma US, bringing experience from previous roles at Astellas Pharma US, GlaxoSmithKline, Genzyme and Quintiles. Peter Bonate holds a 1992 - 1996 PhD in Medical Neurobiology @ Indiana University School of Medicine. With a robust skill set that includes Microsoft Excel, Drug Discovery, Pharmacology, Clinical Research, Customer Service and more, Peter Bonate contributes valuable insights to the industry. Peter Bonate has 5 emails and 1 mobile phone number on RocketReach.